scholarly journals Association of socio-demographic issues with level of knowledge of HIV/AIDS among injecting drug users in Dhaka City in Bangladesh

2017 ◽  
Vol 7 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Nasreen Nahar ◽  
Jesmin Akter ◽  
Md Shahriar Mahbub ◽  
Rabeya Sultana ◽  
Farzana Islam Khan ◽  
...  

 Human Immune Deficiency Virus (HIV) and Acquired immune Deficiency Syndromes (AIDS) continues to be a major burden of morbidity and mortality among the population. Injecting drug users (IDUs) are at high risk of contracting the disease. The study was conducted to assess the level of knowledge of HIV/AIDS and the influence of different socio-demographic factors among IDUs in Dhaka city, Bangladesh. A descriptive type of cross-sectional study was conducted. A total of 200 injecting drug users were selected purposively. A semi-structured questionnaire was used for collecting socio-demographic information of the respondents and their knowledge regarding HIV/AIDS. The level of knowledge was categorized into two: poor (<Mean – 1 SD) and good (≥Mean + 1 SD). The χ2 test was used for finding the association between socio-demographic factors and level of knowledge about HIV/AIDS. Forty-eight percent of the respondents were aged 18-26 years, and 33% were educated up to secondary level. About 47% had an income of Taka 4500-5500. Of the respondents, 41% and 47% were aware of HIV/AIDS and their preventive measures respectively. Age and education of the respondents were significantly (p<0.05) associated with level of knowledge of HIV/AIDS among IDUs. Functional and productive educational campaigns to educate people regarding the health consequences of HIV/AIDS are strongly suggested for creating awareness through disseminating knowledge among IDUs in Bangladesh particularly for the age group with a low level of knowledge and limited access to HIV/AIDS educational intervention programs.South East Asia Journal of Public Health Vol.7(1) 2017: 42-47

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Sheikh Mohammed Shariful Islam ◽  
Tuhin Biswas ◽  
Faiz Ahmed Bhuiyan ◽  
Md. Serajul Islam ◽  
Mohammad Mizanur Rahman ◽  
...  

Introduction and Aim.Injecting drug users (IDUs) are amongst the most vulnerable people to acquisition of HIV/AIDS. This study aims to collect information on IDUs and their health seeking behavior in Bangladesh.Design and Methods.A cross-sectional study was conducted among 120 IDUs attending a drug rehabilitation center in Dhaka, Bangladesh. Data were collected on sociodemographics, drug use, health seeking behavior, knowledge of injecting drugs, and sexual behavior.Results.The mean ± SD and median (IQR) age of the participants were32.5±21.3and 33 (27–38) years, respectively, with only 9.2% females. Injection buprenorphine was the drug of choice for 40% of participants, and 58% of the participants first started drug use with smoking cannabis. 73.3% of participants shared needles sometimes and 57.5% were willing to use the needle exchange programs. 60% of the participants had no knowledge about the diseases spread by injection. Condom use during the last intercourse with regular partners was 11.7% and with any partners 15.8%.Conclusion.IDUs in Bangladesh are a high-risk group for HIV/AIDS due to lack of knowledge and risky behaviors. Education and interventions specifically aimed at IDUs are needed, because traditional education may not reach IDUs or influence their behavior.


1994 ◽  
Vol 42 (4) ◽  
pp. 738-757 ◽  
Author(s):  
Michael Bloor ◽  
Martin Frischer ◽  
Avril Taylor ◽  
Robert Covell ◽  
David Goldberg ◽  
...  

This is an early report of data from an on-going, repeated, cross-sectional study of a community sample of Glasgow injecting drug users. Although HIV was first detected among Glasgow's drug injectors in 1985, data from the first two years of our annual samples (1990 and 1991) indicate that HIV prevalence continues to be low in this population, in the order of 1 or 2 per cent. Possible reasons for this apparent continuing low prevalence are examined. It is suggested that substantial risk reduction – reductions in injection equipment-sharing, reductions in numbers of sharing partners and restrictions in social circles of sharing partners – may have been sufficient reasons, in conjunction with limited contributions to near-stabilisation from the disproportionate attrition of the numerator population through death and cessation of injecting.


2008 ◽  
Vol 137 (7) ◽  
pp. 980-987 ◽  
Author(s):  
M. A. BALOGUN ◽  
N. MURPHY ◽  
S. NUNN ◽  
A. GRANT ◽  
N. J. ANDREWS ◽  
...  

SUMMARYSurveillance reports and prevalence studies have indicated that injecting drug users (IDUs) contribute more to the hepatitis C epidemic in the United Kingdom than any other risk group. Information on both the prevalence and incidence of hepatitis C in IDUs is therefore essential to understanding the epidemiology of this infection. The prevalence of hepatitis C in specimens from the Unlinked Anonymous Prevalence Monitoring Programme collected in 1995, 1996, 1998, 1999, 2000, and 2001 was determined using residual syphilis serology specimens from IDUs attending 15 genitourinary medicine (GUM) clinics in and outside London. These specimens were tested for antibodies to hepatitis C virus (anti-HCV). Using this cross-sectional design, anti-HCV-negative specimens were tested for HCV RNA to identify incident infections during the ‘window’ period of infection, and thus to estimate HCV incidence. Results of the multivariable analysis showed that there was marked variation in prevalence by clinic (P<0·0001) and age (P<0·0001). Overall the majority of infections were in males and the overall prevalence in injectors declined over the study period from 36·9% to 28·7%. The annual incidence in these injectors was estimated as being 3·01% (95% CI 1·25–6·73). Over the study period HCV incidence decreased by 1·2% per year. Genotyping of the incident infections identified the most common genotype as type 1 with type 3 being more frequently seen after 1998. Of the prevalent infections, genotype 1 was the most common. The study has confirmed a higher prevalence of anti-HCV in IDUs in the London area compared to those outside London. How representative of the current injecting drug user population are IDUs attending GUM clinics is unclear. Even so, such studies allow prevalence and incidence to be estimated in individuals who have ever injected drugs and inform ongoing public health surveillance.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Lutango D. Simangwa ◽  
Anne N. Åstrøm ◽  
Anders Johansson ◽  
Irene K. Minja ◽  
Ann-Katrin Johansson

1994 ◽  
Vol 24 (3) ◽  
pp. 527-535 ◽  
Author(s):  
Giovanni Rezza ◽  
Stefania Salmaso ◽  
Damiano Abeni ◽  
Giovanna Brancato ◽  
Alessandra Anemona ◽  
...  

We conducted a study to describe current patterns of drug-related behaviors, and to identify characteristics that may distinguish injecting drug users entering treatment from those out of treatment, in five Italian cities. Overall, 1,180 subjects were recruited — 568 entering treatment and 612 out of treatment. Male to female ratio was 6.6:1. The median age was similar in the two groups. A high proportion of injecting drug users recruited out of treatment had been in treatment at least once. HIV prevalence among injecting drug users entering treatment was not higher than that of those who were out of treatment. Furthermore, a large proportion of injecting drug users who still were out of treatment reported having adopted safe behaviors. The results of the study emphasize the need to implement outreach programs aimed at harm reduction.


Sign in / Sign up

Export Citation Format

Share Document